University of Minnesota. Driven to Discover.
Narrow results
The lack of national flu data is starting to cause worry, especially over novel or resistant strains.
New federal contracts establish a "fill and finish" network for flu vaccine to boost capacity by 20%.
The CDC's final estimates for 2012-13 show a healthy bump in kids and a small gain in adults.
Vaccine advisors today voted in favor of recommending a newly approved recombinant flu vaccine for adults who have an egg allergy.
The US Food and Drug Administration (FDA) has approved Sanofi Pasteur's Fluzone Quadrivalent (four-strain) injectable flu vaccine, the company announced today.
Get news & practices.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»